Figure 1.
Image of nurse applying non-pneumatic shock garment (NASG) to study patient in Nigeria*.
* Both the provider and patient have given informed consent, as outlined in the PLOS consent form, to publication of their photograph.
Table 1.
Clinical trial results for women with shock from maternal hemorrhage, by country, shock severity, and use or non-use of the non-pneumatic anti-shock garment (NASG).
Table 2.
Unit costs by study site, 2010 (Int$)[1].
Table 3.
Treatments and outcomes for standardized cohorts of 1,000 women with shock from maternal hemorrhage, by NASG intervention scenario[1], [2].
Table 4.
Calculated mortality, morbidity, disability-adjusted life years, cost, and cost-effectiveness for 1,000 women with severe or mild shock[1] from maternal hemorrhage, by intervention scenario.
Table 5.
One-way sensitivity analysis on cost and health differences between two intervention scenarios: NASG for severe shock and No NASG.